Trial status
VTE
This study was approved by the University of Michigan IRB on March 16, 2022. Initial alerts (and concomitant randomization procedures) for AF went live on August 1, 2022 in a pilot period. Initial alerts and randomization for VTE and longitudinal notifications for both AF and VTE are planned to go live in March 2023, at which point our 18-month trial period will begin for all alerts and notifications.